Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Recurrent depression without lithium therapy. A lost chance]

J G Pascalis1, A Perceau, T Brochier

  • 1Clinique de Psychiatrie des Adultes, C.H.R.U., Reims, France.

Annales Medico-Psychologiques
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain Charts for the Rhesus Macaque Lifespan.

bioRxiv : the preprint server for biology·2024
Same author

Simultaneous recording of macaque premotor and primary motor cortex neuronal populations reveals different functional contributions to visuomotor grasp.

Journal of neurophysiology·2007
Same author

A cortico-cortical mechanism mediating object-driven grasp in humans.

Proceedings of the National Academy of Sciences of the United States of America·2005
Same author

Patterns of muscle activity underlying object-specific grasp by the macaque monkey.

Journal of neurophysiology·2004
Same author

Investigation into non-monosynaptic corticospinal excitation of macaque upper limb single motor units.

Journal of neurophysiology·2001
Same author

Activity in ventral and dorsal premotor cortex in response to predictable force-pulse perturbations in a precision grip task.

Journal of neurophysiology·2001
Same journal

Annales medico-psychologiques·2023
Same journal

[The effects of the pandemic on students in a psychodynamic setting].

Annales medico-psychologiques·2023
Same journal

[The effects of the COVID-19 pandemic on BAPU students: What analyzes were made by clinicians? The specifics of student care needs in a crisis context].

Annales medico-psychologiques·2023
Same journal

Examining the relationship between the thinking styles and the motivation aspects of the individuals working in the health sector in Turkey during the COVID-19 pandemic: The case of hospital staff.

Annales medico-psychologiques·2022
Same journal

[Psychological impact of the COVID-19 pandemic on children and adolescents and treatments].

Annales medico-psychologiques·2022
Same journal

[Assessing psychological, anxiety, depression and stress levels of Senegalese general population during COVID-19 pandemic].

Annales medico-psychologiques·2022
See all related articles

Lithotherapy using lithium gluconate rapidly improved depressive symptoms in four hospitalized patients within three to seven days. Omitting lithium treatment for recurrent major depressive disorder represents a missed opportunity for effective patient care.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Medicine

Context:

  • Recurrent major depressive disorder presents significant clinical challenges.
  • Hospitalized patients with severe depression require effective and rapid treatment interventions.

Purpose:

  • To evaluate the efficacy of lithotherapy (lithium treatment) in hospitalized patients with recurrent major depressive disorder.
  • To assess the speed of clinical improvement associated with lithium gluconate administration.

Summary:

  • Lithotherapy, specifically using lithium gluconate, demonstrated a favorable clinical evolution in four hospitalized patients with recurrent depression.
  • Rapid therapeutic effects were observed, with symptom improvement occurring within three to seven days of treatment initiation.
  • Lithium's established antidepressant properties underscore its value in managing depressive episodes.

Related Experiment Videos

Impact:

  • The findings suggest that lithotherapy is a valuable and rapid-acting treatment option for recurrent major depressive disorder.
  • The absence of lithium treatment in patients with recurrent major depressive status is a missed therapeutic opportunity.
  • Integrating lithotherapy into treatment protocols could enhance patient outcomes and recovery rates.